Caris Life Sciences (CAI) executive compensation, 2026 proxy

David Dean Halbert, Chief Executive Officer, was paid $20.4M in 2025, up 804% from $2.3M the year before.

Filed
April 23, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
3
CEO total pay
$20.4M+804% vs prior year
CEO pay in equity
76%$15.4M in awards
CEO 2025 Salary
$764,918Reflects earnings for the fiscal year
CEO Target Bonus %
200%Expressed as percentage of eligible earnings
CEO Stock Awards
$15,400,569Includes IPO and shareholder-approved grants
President Total Compensation
$11,583,227Includes option award modifications

How Halbert was paid

$20.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary4%Bonus16%Stock awards76%All other compensation5%

Named executive officers

ExecutiveTotal
David Dean HalbertChief Executive Officer$20,350,571
David SpetzlerPresident$11,583,227
J. Russel DentonSenior Vice President, General Counsel and Secretary$5,354,614

What changed and why

  • $20.4MDavid Dean Halbert received total compensation of $20,350,571 in fiscal year 2025 following the company's initial public offering.
  • 3%Base salaries for named executive officers increased by approximately 3% in February 2025.
  • 115%Annual discretionary cash bonuses for 2025 were awarded at 115% of each named executive officer's target.
  • $1.5MSpecial cash bonuses totaling $1,500,000 were paid to Mr. Halbert for completing private financing and the initial public offering.
  • The company implemented post-IPO restricted stock units and option modifications to align executive interests with shareholders.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.